InvestorsHub Logo
Followers 140
Posts 12688
Boards Moderated 0
Alias Born 04/02/2006

Re: 1234zxcv post# 3854

Saturday, 06/17/2017 9:50:28 AM

Saturday, June 17, 2017 9:50:28 AM

Post# of 11602
CURRENT EMAIL FROM COMPANY....READ HERE....

Kevin - Thank you for your reply and questions. The following outlines our
current thoughts and plans related to being a reporting issuer. When we
filed our original Form 15 (you can see our filing on our website under
Press Releases) the cost to maintain our status with the SEC and FINRA was
anticipated to be in the $225,000 to file our annual filing. At the same
time our cost to file the first quarter was in the neighbourhood of an
additional $20,000. As we had for the previous 15 years paid for these
audit and legal filing costs from the profit of operations of our Canadian
Subsidiaries we could not offset these costs against our Canadian revenue
and as a result we had accumulated a substantial Non-Capital loss in excess
of $4.5 million dollars on our books and records.

Based on this the Directors (I was one and the President of the Company)
felt to continue to add to our Non-Capital loss was and would continue to be
very non-productive. As a result we filed the Form 15 (removing us from
being fully reporting SEC issuer) and remain active as a non-reporting
company while we looked at all our opportunities to re-organize the company
and to move the Company into the US in order to investigate the
opportunities to participate in business operations in the US which would be
cash flow profitable where we could utilize our Non-Capital Losses for the
benefit of the company.

Over the period we were in continual discussions with interested parties but
our due diligence on those opportunities were focussed on profitable
opportunities in order to use those losses. During this period we were
approached on several occasions to examine the opportunities within the
opening up of the legalized marijuana sector particularly in Canada due to
our familiarity of the Canadian marketplace. We made a definitive position
the move to Canadian based revenue streams would put us in the same position
as we had been for the past 15 years in that we would only accumulate
further Non-Capital losses but led us to review opportunities within the
expansion of state legalization within the marijuana space. Based on the
demographics and geographical location and their history within the
medicinal marijuana space we have focussed our attention on California.

In answer to your first question - Timing - It will be based on timing of
our entry into business operations within the US. We will be preparing the
company for audit requirements to commence the process of re-engagement as a
fully reporting issuer. The costs will be reduced due to the fact the
company's subsidiary activities have been re-organized to certain investment
holdings within the financial services centre and will not need the amount
of audit requirements but firm pricing has yet to be determined. I would
expect $100,000+ based on historical activity.

Re: Track & Trace - we have reviewed our opportunities in this part of the
marijuana industry and we are very aware of the Takayama Group's
affiliations due to our financial services experience with this group and
their affiliates. We view the Track and Trace to be just a piece of the
opportunity of a consolidated industry strategy. The one caveat to this is
the fact the various state jurisdictions that are allowing marijuana
business operations are implementing regulated based Track and Trace of
their own and with our involvement with Takayama are determining how the
Seed to Sale "Track and Trace" regulatory program is being initiated we will
continue to engage with Takayama to see if this one segment of the industry
holds the revenue potentials that are being presented to us. So to answer -
yes we are interested but view this a just one part of a consolidated
business model for the medicinal marijuana space and we are looking at all
opportunities and the regulatory requirements for integrated participation
within the space.

I can advise that the legal medicinal marijuana space is where we are
focussing our Corporate attention at this time particularly in California
and Colorado where we are incorporated.

Best regards and thank you for your interest.

Doug Mac Donald, Director and Chief Administration Officer
E-Debit Global Corporation (WSHE)


-----Original Message-----
From: Kevin Fisher [mailto:deepwater@sunflower.com]
Sent: June-14-17 5:30 PM
To: Doug Mac Donald
Subject: Re: edebitglobal.com Contact Us: Form Submission

Thanks for your responses. Further, I would like to ask (1) what is the
anticipated timeline to becoming a "reporting issuer"? weeks? Months? And
is it expensive to do so? and (2) So the Track & Trace program is
definitely the angle you want WSHE to take? Thanks, Kevin.... I
discovered your company on an investors website. I strongly advocate for
traders to buy WSHE stock at that site.

--------------------------------------------------
From: "Doug Mac Donald" <dmacdonald@westsphereasset.com>
Sent: Wednesday, June 14, 2017 11:10 AM
To: <deepwater@sunflower.com>
Cc: <dmacdonald@westsphereasset.com>
Subject: RE: edebitglobal.com Contact Us: Form Submission

> Thank you for your enquiry.
>
> To answer your question re: #1. We have been and are continuing to
> prepare our financials (which are posted on our web-site) to be audit
> ready for future and anticipated return of WSHE to be a "reporting issuer"
with the
> SEC and FINRA filings. Please refer to our web-site for advice of the
> state of development in this regard as we move forward.
>
> To answer your question re: #2. We are in continual and regular
> contact with representatives of Takayama related to management systems
> associated to "Track and Trace" programing while we review the State
> of California test program being initiated in the Humbolt County
> region of California. With pending potential changes in California
> (our specific target of opportunity
> review) oversight and regulation of the entire marijuana space
> scheduled for
> 2018 WSHE through our industry affiliates are monitoring the
> anticipated reporting requirements being developed and regulated "Seed to
Sale"
> tracing
> requirements being initiated. As an aside - based on our Canadian
> experience in financial services sector we are monitoring the current
> state of regulation development of the marijuana space in the various
> regional regions (provinces) and how they are developing the same
> oversight and regulation for the introduction of full recreational and
> medicinal marijuana which will be initiated and scheduled for July 1,
> 2018.
>
> We would like to enquire as to how you heard about our Company we are
> always interested in keeping and open dialogue. Let me know via
> return e-mail if you desire.
>
> Doug Mac Donald, Chief Administration Officer and Director E-Debit
> Global Corporation ("WSHE")
>
>
> ________________________________________
> From: donotreply@godaddy.com [donotreply@godaddy.com]
> Sent: June 6, 2017 1:04 PM
> To: info Edebit
> Subject: edebitglobal.com Contact Us: Form Submission
>
> Name
> Kevin
> Email
> deepwater@sunflower.com
> Subject
> OTC filings and Takayama
> Message
> (1) Are you working on becoming current with your filings with the OTC?
> (2)
> Are you still in contact with Takayama as a partner in business?
> Optin
> False
>
> ________________________________
> This message was submitted from your website contact form:
> http://www.edebitglobal.com/contact-us.html
>
> Use your free GoDaddy Email Marketing Starter account to follow up
> with contacts who agreed to receive email campaigns! Click
> here<https://gem.godaddy.com/promotions?prog_id=GoDaddy&isc=wwbb2459&c
> i=1006 97&cvosrc=bounceback.2459.wwbb2459> to get started.
>
>